Foltz B D, Hessel E A, Ivey T D
J Thorac Cardiovasc Surg. 1984 Aug;88(2):238-47.
In an effort to describe the immediate course of pulmonary hypertension following mitral valve replacement, we reviewed preoperative and postoperative data from 62 patients who underwent mitral valve replacement. Patients were divided based on the absence (Group I) or presence (Group II) of severe preoperative pulmonary hypertension, defined as a mean pulmonary artery pressure greater than or equal to 40 mm Hg. Group II patients were subdivided based on the absence (Group IIa) or presence ( Group IIb) of markedly elevated preoperative pulmonary vascular resistance indices, defined as a greater than or equal to 700 dynes . sec . cm-5 . m2. Pulmonary artery wedge pressures fell promptly following mitral valve replacement in all groups, but the course of other hemodynamic parameters varied among groups. Cardiac index increased significantly among Group I and IIb patients but not among Group IIa patients. Group I patients did not have significant changes in mean pulmonary artery pressure and pulmonary vascular resistance index. Group IIa patients had substantial reductions in mean pulmonary artery pressure while pulmonary vascular resistance index remained near 400 dynes . sec . cm-5 . m2. Group IIb patients had substantial reductions in mean pulmonary artery pressure while pulmonary vascular resistance index fell significantly to about 400 dynes . sec . cm-5 . m2. Primary valvular lesion and pharmacologic support were insignificant variables. Data from these hemodynamic groups suggest that at least three mechanisms contribute to the pulmonary hypertension seen in mitral valve disease: passive transmission of elevated left atrial pressures, reactive pulmonary arteriolar vasoconstriction, and morphologic changes in the pulmonary vasculature. The first two mechanisms appear to be rapidly reversed following mitral valve replacement. While others have described the regression of pulmonary hypertension several months following mitral valve operations, data presented here suggest that changes in pulmonary artery pressures and pulmonary vascular resistance index may occur much earlier.
为了描述二尖瓣置换术后肺动脉高压的近期病程,我们回顾了62例接受二尖瓣置换术患者的术前和术后数据。根据术前是否存在严重肺动脉高压将患者分为两组,严重肺动脉高压定义为平均肺动脉压大于或等于40 mmHg,无严重肺动脉高压者为I组,有严重肺动脉高压者为II组。II组患者再根据术前肺血管阻力指数是否显著升高进一步细分,肺血管阻力指数大于或等于700达因·秒·厘米⁻⁵·米²者为IIb组,无显著升高者为IIa组。所有组二尖瓣置换术后肺动脉楔压均迅速下降,但其他血流动力学参数的变化在各组间有所不同。I组和IIb组患者的心排血指数显著增加,而IIa组患者则无明显变化。I组患者的平均肺动脉压和肺血管阻力指数无显著变化。IIa组患者的平均肺动脉压大幅降低,而肺血管阻力指数仍接近400达因·秒·厘米⁻⁵·米²。IIb组患者的平均肺动脉压大幅降低,而肺血管阻力指数显著下降至约400达因·秒·厘米⁻⁵·米²。原发性瓣膜病变和药物支持是无关变量。这些血流动力学分组的数据表明,至少有三种机制导致二尖瓣疾病中出现的肺动脉高压:左心房压力升高的被动传导、反应性肺小动脉血管收缩以及肺血管的形态学改变。二尖瓣置换术后前两种机制似乎迅速逆转。虽然其他人描述了二尖瓣手术后数月肺动脉高压的消退,但此处呈现的数据表明,肺动脉压和肺血管阻力指数的变化可能发生得更早。